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An  ultrastructurally  typical  virus-like filtrable  agent  has  been  recovered 
from NZB/B1 mice (1); at the same time, preliminary observations have been 
reported on the activity of the agent in Swiss mice. The present study, an ex- 
tension of this work, points to two (perhaps related) circumstances which may 
be  requisites for  the  pathogenic  action  of  this  agent  within  and  outside  the 
strain NZB: infection of newborn, or fiffant, mice; persistent, possibly tolerant, 
infection of adult mice. 
Methods and Materials 
Animals.--The care and the methods of study of our colony of NZB/B1 mice, derived from 
breeding stock provided by Dr. Marianne Bielschowsky and now in the 70th generation of 
brother-sister matings, are described elsewhere (1, 2). 
A male CBA/T6 mouse, in a breeding nncleus obtained from Jackson Laboratories (Bar 
Harbor, Maine) by Dr. Eugene  Lance, was crossbred with an NZB/B1  female to obtain the 
CBA c~ X  NZB  ~  F1 hybrids. 
Adult Webster-Swiss mice  (Carworth Farms, New City, N. Y.) were used as short-term 
random breeders to obtain newborn mice. In addition, six pregnant female gnotobiotic CFW 
mice were obtained from Carworth Farms to lYrovide  newborn mice through the courtesy of 
Mr. Dennis Baker. The digestive microtlora (3) associated  with the gnotobiotic colony in- 
eluded lactobacilli,  streptococci (Group N), and enterococci. A panel of eight serological tests 
(to be discussed below) for routine virus antibodies had been performed on 18 of the 72 gnoto- 
biotic CFW mice in the Carworth colony, in each instance with negative results. 
Adult Swiss mice were obtained frbm a colony (Charles River Farms, North Wilmington, 
Mass.) known to be free from infection with lymphocytic choriomeningitis  (LCM) virus and 
were used as provisional intermediate hosts in experiments described below. 
Murine Virus Antibody Determinatious.--These serological tests were  performed by Dr. 
John C. Parker of Microbiological Associates, Inc.  (Washington,  D.C.) on serums obtained 
from 10 aged NZB/BI mice, long residents in our nonbreeding  NZB/BI mouse rooms.  The 
serological procedures (see reference 8) are indicated in Table IV: hemagglutiuation-inhibition 
method for antibodies against pneumonitis virus of mice (PVM), reovirns 3, K, Sendai, Theiler 
GD VII, and polyoma virus; complement-fixation method for antibodies against mouse adeno- 
virus and mouse hepatitis virus. 
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An indirect method was used to determine whether NZB/B1 mice harbored a latent (vire- 
mic) infection with LCM virus (4) : 0.2 mi of fresh whole blood was collected from each of 10 
young (2-3 months old) NZB/BI mice and was injected intraperitoneally into an equal number 
of Swiss mice obtained from a colony known to be free from infection with this virus. At 28 
days, the recipient Swiss mice were bled and the serums were tested for the presence of comple- 
ment-fixing antibody against LCM virus (Table IV), normally absent from these mice but 
inducible in the event of infection. 
Cell-Free Filtrates.--Using  standardized methods described elsewhere (1), cell-free filtrates 
were prepared mainly from individual spleens obtained from 17-20 months old NZB/B1 mice 
which presented the characteristic findings  of autoimmune hemolytic disease (5, 6), including 
positive antiglobulin  (Coombs')  tests,  anemia,  reticulocytosis,  and  splenomegaly.  In some 
instances, the spleen filtrates were carried a step beyond the customary purification procedure 
by further centrifugation for 60 min at 23,000 rpm (30,000 g) in a Spinco model L preparative 
ultracentrifuge. The pellets so formed were then reconstituted in pH 7.2 buffered saline so that 
1 ml was equivalent to 0.2 g weight of spleen (as with all filtrates). These "purified" cell-free 
filtrates were, as all others, passed  through sterile Millipore filters with rated porosities of 
0.45 tt or 0.22 tt and shown to be capable of retaining marker bacteria (Serratia marcescens). 
The standard  filtrate contained about  1 mg protein  (or organic material)  per milliliter, the 
purified filtrate about 0.08  mg protein per milliliter. Newborn and infant mice received an 
intraperitoneal injection of 0.25 ml of filtrate, older mice 0.5 mi of filtrate. 
Experimental  Design.--To  date,  50 filtrates of NZB/B1 mouse tissues,  including spleen, 
kidney, liver, lung, and lymphoma have been prepared;  15 of these preparations have been 
inoculated into more than 150 Swiss and CBA/T6 mice, in many instances for the purpose of 
long-term studies which are in progress. The present report is based upon initial studies with 
four NZB/B1 spleen filtrates which were found to be biologically active when injected intra- 
peritoneaUy into newborn or very young (less than 1 wk old)  Swiss mice, including the 1 day 
old progeny of gnotobiotic CFW females, but not when injected into Swiss mice at 6 wk of 
age. NZB/B1 lymphoma filtrate had previously been found inactive with respect to induction 
of hemolytic and renal disease when injected into 2-3 wk old Swiss mice (1). 
RESULTS 
Swiss Mice 
Control Observations.--Normal  healthy adult Swiss mice were found by urin- 
analysis to have (--) or at most (+)  proteinuria. The normal average and the 
95 % confidence interval, based upon 10-20 individual determinations, of those 
blood constituents immediately relevant to the present study are given in Table 
I. The laboratory findings on numerous Swiss mice under observation in our 
mouse colony during the period of this study were, with rare exception, normal 
by the criteria just mentioned, as were the data obtained on a group of Swiss 
mice  injected  at 3  wk with an NZB/B1  lymphoma filtrate.  81  direct  and 41 
indirect antiglobulin (Coombs') tests at 37°C were performed on 81 adult Swiss 
mice,  and all tests were  negative. Having no evidence  of either hemolytic or 
renal disease,  these animals served as controls for the observations on inocu- 
lated mice presented here. 
ttemolytic Disease.--Some  of the indications that hemolytic disease was in- 
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free filtrate into newborn and in/ant mice are given in Table II. The changes 
occurred in 2-5 months, frequently near the middle of this time interval, and 
often persisted through a major segment of the period of observation, which is 
being continued. The indirect antiglobulin (Coombs')  test performed for in- 
TABLE I 
LaboroZory Examinations  of Healthy Adult Swlss Mice 
Average -4- 2 sD (956"/o 
Determination  Average  confidence  interval) 
Hematocrit, % 
Reticulocytes, % 
Platelets/mm  8 
WBC/mm  s 
Serum ure~ nitrogen,  mg/lO0 ml 
Serum cholesterol,  mg/lO0 ml 
52 
2 
1,590,000 
10,750 
Serum proteins, g/lO0 nd 
Total 
Albumin 
al-globulins 
~.  ,, 
5.7 
2.7 
0.5 
0.8 
1.0 
0.7 
25 
133 
44--60 
0-3 
1,250,000-1,950,000 
5,500-18,100 
17-33 
73-193 
5.1-6.3 
2.0-3.4 
0.2-0.8 
0.6-1.0 
0.6-1.4 
0.5-0.9 
TABLE II 
Evidence of Hemolytic Disease in Swiss Mice at 2-5 Months After Inoculation 
of Cdl-Free Fillrale 
Abnormality 
Indirect Coombs' test~ 
Reticulocytosis 
Anemia 
Criterion* 
Positive 
Ret.  >  3% 
Hct.  <  44% 
Mice 
Per cent  [  Fraction 
1  i  ]  (5/29) 
2  (10/36) 
(3/40) 
Range of 
abnormality 
per cenl 
4-20 
41---43 
* Values outside 2 sv interval for the normal (see Table I). 
:~ Papain method, using erythrocytes of Swiss mice, 
complete antibodies active at 37°C became positive in 17 %  (5  of 29)  of the 
inoculated mice, at low serum titers  (approximately 1:2)  comparable to the 
early findings on young NZB/B1 mice prior to positive conversion in the direct 
test. Papain-treated Swiss mouse erythrocytes of either homologous or autolo- 
gous source  served  equally  well  as  test  antigens.  The  direct  antiglobulin 
(Coombs') tests have remained negative to date. Reticulocytosis developed in 
28 %  (10 of 36)  of the inoculated mice, and low grade anemia occurred in 8 % 56  tM'MUNOPATHOLOGY O1~" NZB/BL  MICE 
(3 of 40). It must be emphasized that the method of study always utilized the 
collection of minimal samples of blood by a single bleeding at monthly or longer 
intervals, a procedure which in our experience  does not factitiously induce re- 
ticulocytosis and anemia in normal Swiss mice. 
Autopsies and histological  examinations of major organs were performed on 
five of the inoculated mice. The presence in four mice of both vigorous (eryth- 
roid and myeloid) hematopoiesis and prominent hemosiderosis  in spleen and to 
a certain extent liver, in our experience unusual findings in untreated Swiss mice 
of comparable age, provided substantiating evidence of hemolytic disease. 
Renal Disease.--Some  of the indications that renal disease was induced in 
Swiss mice by the intraperitoneal inoculation of NZB/B1 spleen cell-free filtrate 
into newborn and infant mice is presented in Table HI. These changes occurred 
TABLE III 
Eddence of Renal Disease in Swiss M~e at 2-5 Months after Inoculation o/ 
Call-free Filtrate 
Abnorm~ity 
Proteinuria 
Hypoalbuminemia 
Elevated a~-globulins 
Hypergammaglobu- 
linemia 
Hypercholesterolemia 
Criterion* 
>+ 
<2  g/100 ml 
>1  g/100 ml 
>0.9  g/100  ml 
>193mg/100ml 
Mice 
Per cent  Fraction 
27  (11/4i) 
21  (6/29) 
24  (7/29) 
76  ~22/29) 
41  (17/42) 
Range o~ 
abnormality 
++ to +++ 
0.9-1.9  g/100  ml 
1.1-1.2  g/100  ml 
1.0-2.3  g/100  ml 
196-250 rag/100 ml 
* Values outside 2 sv interval for the normal (see Table I). 
in 2-5 months and,  once developed, tended to persist. Significant  proteinuria 
(++  to q-++)  occurred in 27%  (ll  of 41)  of the inoculated mice, hypoal- 
bumlnemia in 21%  (6 of 29),  elevated as-globulins in 24%  (7 of 29),  hyper- 
gammaglobulinemia in 76% (22 of 29), and hypercholesterolemia in 41% (17 of 
42). An impressive example of induced hypergammaglobulinemia is shown in 
Text-fig.  1. 
Histological examinations  of major  organs  of five of  the  inoculated  mice 
revealed the following data: in all, intense lymphoid cell and plasma cell hyper- 
plasia of spleen and lymph nodes; in three, plasma cell hyperplasia (infiltration) 
of thymus with relative depletion of lymphocytes; in two, atrophy of cortex and 
medulla of thymus; and in three, renal glomerular lesions. The renal changes 
consisted of an homogeneous thickening and alteration of the glomerular capil- 
lary basement membrane (Fig. 1) and an accumulation of basement membrane- 
like materials in the axis of the glomerular tuft. These changes were usually 
focal, that is, they involved some but not all of the glomeruli  in the kidneys, ROBERT  C.  MELLORS  AND  Ctl~N  YA  HUANG  57 
and segmental,  that is,  they affected a part d  an individual glomerulus and 
were similar  to those seen in the early phases of "spontaneous"  (9,  10)  and 
experimentally accelerated (9) renal disease of NZB/B1 mice.  Lesions of this 
type were not seen in the kidneys of control Swiss mice of comparable age (Fig. 
2). 
Murine Virology 
Antibody Determinations.--Serological tests for evidence of prior immunizing 
nfection of old NZB/B1 mice with pneumonitis virus of mice (PVM), reovirus 3, 
y  ~  a2  al  A 
"I'zxT-FIG. 1.  Paper electrophoresis pattern for serum proteins of a  Swiss mouse inoculated 
with NZB/BI  cell-free  filtrate. Albumin (A) migration to the right. Total protein, 8.0 g/100 ml; 
A, 1.8; al-globulins, 0.5; as, 1.1; fl, 2.2; % 2.4. 
mouse adenovirus, and mouse hepatitis virus as well as for evidence of latent 
(viremic) infection of young NZB/BI mice with lymphocytic choriomeuingitis 
(LCM) virus were negative in each of 10 determinations  (Table IV).  Anti- 
bodies against K virus and against Sendai virus were present in serum specimens 
4 and 5 respectively. Serological tests for antibodies against GD VII virus and 
against polyoma virus were positive in each instance. 
Electron Microscopy.--Virus-like  particles, with close ultrastructural  resem- 
blance to the type "C" murine oncogenic virus particles and indistinguishable 
from those previously described  (1),  were identified in  lymphoid  and  renal 
tissues by electron microscopy. The virus-like particles were present in distinc- 
tive intra- and extracellular locations, notably in the latter respect in the basal 58  rM3/UNOPATHOLOGY OF NZB/BL MICE 
foldings  of renal  tubules,  of an embryonic  (18  day  stage)  NZB/B1  mouse in- 
utero, a newborn NZB/B1  mouse (Fig. 3),  15-17 month old NZB/B1  mice, a 3 
wk old hybrid mouse produced by the cross CBA C  X  NZB  9  (Fig. 4), and a 
Swiss mouse (the progeny of a gnotobiotic CFW female) at 4 wk after receiving 
an  intraperitoneal  injection  of  a  purified  cell-free  filtrate  of  NZB/BI  mouse 
spleen  (Fig 5).  Similar particles  were  not found on equivalent  examination  of 
the tissues of untreated Swiss and CBA mice. 
TABLE IV 
Murine Virus Antibody Determinalions on 10 NZB/BI Mic~ 
(21-23 Months Old) 
Specimen 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
Initial test 
dilution 
PVM 
1:20 
Serum end point tltrations 
Hem  agglu  tination-inhibition  test 
Reo 3  K 
~1:40 
1:20  1:10 
Sendai 
1:40 
1:10 
I 
GD VII  Polyoma 
1:80 
1:80 
1:80 
~1:20 
1:40 
1:40 
1:20 
1:320 
1:160 
1:40 
1:20 
1:320 
1:160 
1:320 
~1:40 
1:320 
1:160 
1:160 
1:320 
1:320 
1:320 
1:20 
Complement fixation test 
Mouse  Mouse 
adenc~  hep.atitis  LCM* 
virus  virus 
-~  -~  - 
--~  - 
-~  -~t  - 
1:10  1:10  1:10 
* These serological  tests were performed on Swiss mice which 28 days previously had re- 
cciveM  intraperitoneal injections of 0.2 ml fresh whole blood obtained from young (2-3 months 
old) NZB/BI mice. 
Negative at 1: 20, anticomplementary activity at 1:10 dilution. 
DISCUSSION 
With respect to both ultrastructure and pathogenic effects, assuming these 
to be attributes of one and the same agent, the virus of NZB/B1 mice appears 
to be an entity not represented by the viruses listed in Table  IV. For example 
K virus of mice (11) shares many properties of the papovaviruses (12);  Sendal 
virus is a murine parainfluenza virus (13);  GD VII virus (14)  is a murine pi- 
comavirus and causes encephalomyelitis of mice; polyoma virus is a  murine 
papovavirus capable of causing tumors of diverse histogenesis, including those 
of salivary gland  origin,  in  mice  (15).  Neutralization  studies which  require ]ROBERT  C.  ~LLORS  AND  CH.EN  YA  B'UANG  59 
specific antiserums and, preferably, a more convenient bioassay system should 
determine the antigenic relation,  if any, to known murine  oncogenic  viruses 
(16--19) with typical type "C" ultrastructure. 
According to the four postulates of Koch, reaffirmed for virology by Rivers, 
proof that a microorganism causes a disease is established by (a) demonstrating 
the occurrence of the microorgani.~m in association with  the disease,  (b) iso- 
lating  this microorganism in pure culture (or tissue culture),  (c) reproducing 
the disease in susceptible animals by inoculation of the microorganism in pure 
culture,  (d) finding  the microorganism in the susceptible animals.  Our studies 
have consistently demonstrated that typical virus-like particles are present in 
the nephrons of NZB/B1 mice from birth until  advanced age. The virus-like 
particles have been identified in the urinary space and the epithelial cells (podo- 
cytes) of the glomeruli,  in the lumens and the basal foldings of the renal con- 
voluted tubules, and in lymphoid cells of spleen and thymus. Renal and hemoly- 
tic  diseases,  with  early functional  and  structural  changes  similar  to  those 
occurring  in  NZB/B1  mice  at  comparable  age  (10),  were induced  in  Swiss 
mice by inoculating them, as newborns or infants, with cell-free  filtrates pre- 
pared from the spleens of adult NZB/B1 mice. Typical virus-like  particles were 
identified in the nephrons of an inoculated Swiss mouse. In vitro studies utilizing 
tissue cultures for the isolation of the virus are next to be undertaken. 
These facts point to two circumstances which may be requisites for the patho- 
genic action of this viral agent within and outside the strain NZB: infection of 
newborn, or infant,  mice or of embryos in utero; persistent infection of adult 
mice. While viruses are known to be protected by fixation to the living cells of 
susceptible animals  (23),  which in itself can account for persistent infection, 
the combined features of congenital (or neonatal)  infection and abundance of 
virus-like particles in extracellular sites resemble those observed in mice with 
persistent tolerant infection with lymphocytic choriomeningitis  virus (20).  In 
fact, renal disease,  with glomerular lesions  and perivascular accumulations of 
lymphocytes and plasma cells similar  to those occurring  in NZB/B1 mice, is a 
prominent aspect of the "late onset disease" which develops in these tolerant 
mice (20). Hotchin and Collins have suggested (20) that this late onset disease 
may occur as a result of the gradual  waning  of immunological  tolerance for- 
merly exhibited by the mouse towards an otherwise harmless virus infection or, 
alternatively, may arise  from a  slow cytopathic effect of the virus on target 
organs such as the kidneys. An early study (21) in which neonatal thymus of 
NZB/B1 mice was transplanted  to neonatally thymectomized CBA/T6 mice, 
resulting  in the induction of autoimmune hemolytic and renal disease in the 
latter, might find eventual explanation in virus, as well as lymphoid cell, trans- 
fer. 
The  findings  in viral  plasmacytosis  (Aleutian  disease)  of mink  (22)  bear 
similarity to those which prevail  in NZB/B1 mice  (10):  hypergammaglobuli- 60  IMMUNOPATHOLOGY OF  NZB/BL MICE 
nemia, overproliferation of plasma cells,  glomerular and vascular lesions, and 
genetic predisposition  (for Aleutian and  related  color  types).  Recently this 
viral  infection has  been  experimentally transmitted  to  standard  dark  (not 
Aleutian) mink and has been shown to induce positive antiglobulin (Coombs') 
test conversion in these animals at about 8 months (22). 
SUMMARY AND CONCLUSIONS 
Hemolytic  disease  characterized  by  slight  anemia,  reticulocytosis, 
hemosiderosis, extramedullary hematopoiesis, and positive indirect antiglobulin 
(Coombs')  tests  and  renal  disease with proteinuria, hypoalbuminemia, and 
glomerular lesions were produced in  Swiss  mice by neonatal intraperitoneal 
inoculation of cell-free filtrates prepared from the spleens of old NZB/BI mice. 
Lymphoid cell and plasma cell hyperplasia as well as hypergammaglobulinemia 
occurred in some of these inoculated mice. 
Type "C" routine oncogenic virus-like particles, indistinguishable from those 
previously described  (1),  were  shown  by  electron  microscopic  study  to  be 
present  in distinctive locations, notably in the basal foldings of convoluted 
tubules in the kidneys of a newborn NZB/BI mouse, old NZB/B1 mice, a CBA 
X  NZB F1 hybrid mouse, and a Swiss mouse inoculated with NZB/B1 spleen 
cell-free filtrate. 
These observations point to two (perhaps related) circumstances which may 
be requisites for the pathogenic action of this newly discovered virus within 
and outside the strain NZB: infection of newborn,  or infant, mice; persistent, 
possibly tolerant, infection of adult mice. 
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Addendum.--In  a continuation of this work, 3 of 28 Swiss mice were found at 7 
months after inoculation with NZB/B1 cell-free filtrate to have developed malignant 
lymphoma with similar organ distribution and leukemic blood picture,  and in addi- 
tion to have hemolytic  disease and progressive renal  disease (diffuse membranous 
glomerulonephritis).  The  incidence  of induced  lymphoma (~10%)  was  about  10 
times the incidence of spontaneous lymphoma (HI %) observed in 100 control Swiss 
mice. 
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EXPLANATION OF PLATES 
PLATE 5 
FIG.  1. Kidney (cortex)  of Swiss mouse inoculated with NZB/B1 spleen  cell-free 
filtrate.  Membranous  and  mesangial  lesions  involving a  segment  of a  glomerulus. 
2/z section. Periodic acid-Schiff stain,  ×  1800. 
FIG. 2. Kidney (cortex)  of a control Swiss mouse. A normal glomerulus. 2/z sec- 
tion.  Periodic acid-Schiff stain,  ×  1500. THE JOURNAL OF EXPERIMENTAL MEDICINE VOL.  126  P~ATE  5 
(Mellors and Huang: Immunopathology of NZB/BI mice) I~LATE 6 
Ftcs.  3-S.  Electron  micrographs of  thin  sections fixed  with  glutaraidehyde and 
osmium tetroxide and double-stained with uranyl acetate and lead acetate.  ×  60,000. 
Ultrastructurally similar virus-like particles are present within the spaces of basal 
foldings of proximal convoluted tubules in  the kidneys of newborn  NZB/B1  mouse 
(Fig. 3), a  CBA  X  NZB F~ hybrid mouse (Fig. 4), and a Swiss mouse inoculated with 
NZB/B1  spleen  cell-free filtrate  (Fig.  8). THE  JOURNAL OF  EXPERIMENTAL MEDICINE  VOL. 126  PLATE 6 
(Mellms and Huang: Immunopathology of NZB/BI mice) 